• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The use of ex vivo-activated memory T cells (autolymphocyte therapy) in the treatment of metastatic renal cell carcinoma: final results from a randomized, controlled, multisite study.

作者信息

Graham S, Babayan R K, Lamm D L, Sawczuk I, Ross S D, Lavin P T, Osband M E, Krane R J

机构信息

Department of Urology of Emory University School of Medicine, Atlanta, GA.

出版信息

Semin Urol. 1993 Feb;11(1):27-34.

PMID:8465126
Abstract
摘要

相似文献

1
The use of ex vivo-activated memory T cells (autolymphocyte therapy) in the treatment of metastatic renal cell carcinoma: final results from a randomized, controlled, multisite study.体外激活记忆T细胞（自体淋巴细胞疗法）在转移性肾细胞癌治疗中的应用：一项随机、对照、多中心研究的最终结果。
Semin Urol. 1993 Feb;11(1):27-34.
2
Autolymphocyte therapy for metastatic renal cell carcinoma: initial clinical results from 335 patients treated in a multisite clinical practice.转移性肾细胞癌的自体淋巴细胞疗法：多中心临床实践中335例患者的初步临床结果
Transplant Proc. 1992 Dec;24(6):3059-64.
3
Autolymphocyte therapy in the treatment of metastatic renal cell carcinoma.自体外周血淋巴细胞疗法治疗转移性肾细胞癌
Urol Clin North Am. 1993 May;20(2):297-301.
4
Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.细胞疗法：转移性肾细胞癌治疗的科学原理与临床结果
Semin Oncol. 1995 Feb;22(1):74-80.
5
Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma.自体淋巴细胞疗法对转移性肾细胞癌患者生存率和生活质量的影响。
Lancet. 1990 Apr 28;335(8696):994-8. doi: 10.1016/0140-6736(90)91064-h.
6
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.伴有下腔静脉侵犯的转移性肾细胞癌：根治性肾切除术、腔静脉血栓切除术及术后免疫治疗联合治疗后的长期生存情况
J Urol. 1999 Jul;162(1):46-50. doi: 10.1097/00005392-199907000-00012.
7
No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?转移性肾细胞癌完全转移灶切除术后辅助全身治疗无作用？
Urol Oncol. 2007 Jul-Aug;25(4):310-6. doi: 10.1016/j.urolonc.2006.08.022.
8
[Biotherapy of advanced cancer by infusion of in vitro activated autolymphocytes].[通过输注体外激活的自体淋巴细胞对晚期癌症进行生物治疗]
Zhonghua Zhong Liu Za Zhi. 1995 Nov;17(6):464-6.
9
Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.无腹膜后淋巴结肿大可预测转移性肾细胞癌患者的生存情况。
J Urol. 2001 Jul;166(1):68-72.
10
A phase I trial of CD3/CD28-activated T cells (Xcellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinoma.一项针对转移性肾细胞癌患者的CD3/CD28激活T细胞（加速T细胞）与白细胞介素-2的I期试验。
Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3562-70.

引用本文的文献

1
Harnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directions.利用程序性死亡受体-1（PD-1）通路治疗肾细胞癌：当前证据与未来方向
BioDrugs. 2014 Dec;28(6):513-26. doi: 10.1007/s40259-014-0111-4.
2
Adoptive T cell therapy for cancer in the clinic.临床上用于癌症治疗的过继性T细胞疗法。
J Clin Invest. 2007 Jun;117(6):1466-76. doi: 10.1172/JCI32446.
3
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.肾细胞癌患者中的共刺激分子B7-H1：肿瘤侵袭性指标及潜在治疗靶点
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17174-9. doi: 10.1073/pnas.0406351101. Epub 2004 Nov 29.
4
High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma.
J Neurooncol. 1995;23(3):253-6. doi: 10.1007/BF01059958.